The presence of inter tumor heterogeneity implies that a one-size-fits-all approach to cancer treatment is often inadequate. It underscores the need for personalized treatment plans that consider the unique characteristics of each tumor. Targeted therapies and immunotherapies are examples of treatments that can be tailored to the specific molecular profile of a patient's tumor, potentially improving outcomes and reducing side effects.
